ArticleThe oncologist2017
A Phase Ib Study of Sorafenib (BAY 43-9006) in Patients with Kaposi Sarcoma.
Thomas S Uldrick et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it
ArticleThe oncologist2017
Thomas S Uldrick et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.